2023 |
Revance Therapeutics Inc
|
Independent Director |
315.0 K |
6.1 % |
2023 |
ArriVent BioPharma Inc.
|
Independent Director |
79.3 K |
0.0 % |
2022 |
Revance Therapeutics Inc
|
Independent Director |
297.0 K |
-0.6 % |
2022 |
ArriVent BioPharma Inc.
|
Independent Director |
79.3 K |
- |
2021 |
Revance Therapeutics Inc
|
Independent Director |
298.7 K |
-1.2 % |
2021 |
Ambrx Biopharma Inc - ADR
|
Independent Director |
- |
- |
2020 |
Revance Therapeutics Inc
|
Independent Director |
302.4 K |
18.2 % |
2020 |
Ambrx Biopharma Inc - ADR
|
Independent Director |
- |
- |
2019 |
Revance Therapeutics Inc
|
Independent Director |
255.9 K |
- |